EXTAVIA (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the EXTAVIA drug offered from Novartis Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | Interferon beta-1b |
SUBSTANCE NAME: | |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2009-08-14 |
END MARKETING DATE: | 0000-00-00 |
EXTAVIA HUMAN PRESCRIPTION DRUG Details:
Item Description | EXTAVIA from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2009-08-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0569_ccbcd313-1b72-4f00-882a-559a002136bf |
PRODUCT NDC: | 0078-0569 |
APPLICATION NUMBER: | BLA125290 |